Advertisement

Apoptosis

, Volume 12, Issue 8, pp 1443–1453 | Cite as

Clostridium difficile toxin A-induced apoptosis is p53-independent but depends on glucosylation of Rho GTPases

  • Stefanie Nottrott
  • Janett Schoentaube
  • Harald Genth
  • Ingo Just
  • Ralf GerhardEmail author
Original Paper

Abstract

Clostridium difficile toxin A (TcdA) is one of two homologous glucosyltransferases that mono-glucosylate Rho GTPases. HT29 cells were challenged with wild-type and mutant TcdA to investigate the mechanism by which apoptosis is induced. The TcdA-induced re-organization of the actin cytoskeleton led to an increased number of cells within the G2/M phase. Depolymerization of the actin filaments with subsequent G2/M arrest, however, was not causative for apoptosis, as shown in a comparative study using latrunculin B. The activation of caspase-3, -8, and -9 strictly depended on the glucosylation of Rho GTPases. Apoptosis measured by flow cytometry was completely abolished by a pan-caspase inhibitor (z-VAD-fmk). Interestingly, cleavage of procaspase-3 and Bid was not inhibited by z-VAD-fmk, but was inhibited by the calpain/cathepsin inhibitor ALLM. Cleavage of procaspase-8 was susceptible to inhibition by z-VAD-fmk and to the caspase-3 inhibitor Ac-DMQD-CHO, indicating a contribution to the activation of caspase-3 in an amplifying manner. Although TcdA induced mitochondrial damage and cytochrome c release, p53 was not activated or up-regulated. A p53-independent apoptotic effect was also checked by treatment of HCT 116 p53−/− cells. In summary, TcdA-induced apoptosis in HT29 cells depends on glucosylation of Rho GTPases leading to activation of cathepsins and caspase-3.

Keywords

Apoptosis Rho GTPases Clostridium difficile p53 Caspases Cell cycle Actin cytoskeleton Glucosyltransferase 

Abbreviations

TcdA/TcdB

C. difficile toxin A/toxin B

CPE

Cytopathic effect

CTE

Cytotoxic effect

FACS

Fluorescence-associated cell sorting

GAPDH

Glyceraldehyde-3-phosphate dehydrogenase

GT

Glucosyltransferase

z-VAD-fmk

Benzyloxycarbonyl-Phe-Val-Ala-Asp-(Ome)-fluoromethyl-ketone

Ac-DMQD-CHO

Acetyl-Asp-Met-Gln-Asp-CHO

ALLM

N-Acetyl-Leu-Leu-Met

Notes

Acknowledgments

We are grateful to Helma Tatge for excellent technical assistance, and we also thank Hanping Feng, Tufts University, for critical reading of the manuscript. This study was supported by Deutsche Forschungsgemeinschaft SFB621 (Project B5) and SPP1150 (Project GE 1247/1-2). HCT 116 p53−/− and wild-type cells were kindly provided by Bert Vogelstein, Baltimore, USA.

References

  1. 1.
    Just I, Gerhard R (2004) Large clostridial cytotoxins. Rev Physiol Biochem Pharmacol 152:23–47PubMedCrossRefGoogle Scholar
  2. 2.
    Just I, Selzer J, Wilm M, Von Eichel-Streiber C, Mann M, Aktories K (1995) Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375:500–503PubMedCrossRefGoogle Scholar
  3. 3.
    Hall A (1998) Rho GTPases and the actin cytoskeleton. Science 279:509–514PubMedCrossRefGoogle Scholar
  4. 4.
    Jaffe AB, Hall A (2005) Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 21:247–269PubMedCrossRefGoogle Scholar
  5. 5.
    Ridley AJ (2001) Rho proteins: linking signaling with membrane trafficking. Traffic 2:303–310PubMedCrossRefGoogle Scholar
  6. 6.
    Aznar S, Lacal JC (2001) Rho signals to cell growth and apoptosis. Cancer Lett 165:1–10PubMedCrossRefGoogle Scholar
  7. 7.
    Symons M (1996) Rho family GTPases: the cytoskeleton and beyond. Trends Biochem Sci 121:178–181CrossRefGoogle Scholar
  8. 8.
    Coleman ML, Olson MF (2002) Rho GTPase signalling pathways in the morphological changes associated with apoptosis. Cell Death Diff 9:493–504CrossRefGoogle Scholar
  9. 9.
    Coniglio SJ, Jou TS, Symons M (2001) Rac1 protects epithelial cells against anoikis. J Biol Chem 276:28113–28120PubMedCrossRefGoogle Scholar
  10. 10.
    Fritz G, Kaina B (2006) Rho GTPases: promising cellular targets for novel anticancer drugs. Curr Cancer Drug Targets 6:1–14PubMedCrossRefGoogle Scholar
  11. 11.
    Fiorentini C, Falzano L, Travaglione S, Fabbri A (2003) Hijacking Rho GTPases by protien toxins and apoptosis: molecular stratagies of pahtogenic bacteria. Cell Death Diff 10:147–152CrossRefGoogle Scholar
  12. 12.
    Brito GA, Carneiro-Filho B, Oria RB, Destura RV, Lima AA, Guerrant RL (2005) Clostridium difficile toxin A induces intestinal epithelial cell apoptosis and damage: role of Gln and Ala-Gln in toxin A effects. Dig Dis Sci 50:1271–1278PubMedCrossRefGoogle Scholar
  13. 13.
    Carneiro BA, Fujii J, Brito GA et al (2006) Caspase and bid involvement in Clostridium difficile toxin A-induced apoptosis and modulation of toxin A effects by glutamine and alanyl-glutamine in vivo and in vitro. Infect Immun 74:81–87PubMedCrossRefGoogle Scholar
  14. 14.
    Brito GA, Fujji J, Carneiro-Filho BA, Lima AA, Obrig T, Guerrant RL (2002) Mechanism of Clostridium difficile toxin A-induced apoptosis in T84 cells. J Infect Dis 186:1438–1447PubMedCrossRefGoogle Scholar
  15. 15.
    Liu TS, Musch MW, Sugi K et al (2003) Protective role of HSP72 against Clostridium difficile toxin A-induced intestinal epithelial cell dysfunction. Am J Physiol 284:C1073–C1082Google Scholar
  16. 16.
    Brito GAC, Fujji J, Carneiro BA, Lima AAM, Obrig T, Guerrant RL (2002) Mechanism of Clostridum difficile toxin A-induced apoptosis in T84 cells. J Infect Dis 186:1438–1447PubMedCrossRefGoogle Scholar
  17. 17.
    Mahida YR, Galvin A, Makh S et al (1998) Effect of Clostridium difficile toxin A on human colonic lamina propria cells: early loss of macrophages followed by T-cell apoptosis. Infect Immun 66:5462–5469PubMedGoogle Scholar
  18. 18.
    Fiorentini C, Fabbri A, Falzano L et al (1998) Clostridium difficile toxin B induces apoptosis in intestinal cultured cells. Infect Immun 66:2660–2665PubMedGoogle Scholar
  19. 19.
    Le SS, Loucks FA, Udo H et al (2005) Inhibition of Rac GTPase triggers a c-Jun and Bim-dependent mitochondrial apoptotic cascade in cerebellar granule neurons. J Neurochem 94:1025–1039PubMedCrossRefGoogle Scholar
  20. 20.
    Hippenstiel S, Schmeck B, N’Guessan PD et al (2002) Rho protein inactivation induced apoptosis of cultured human endothelial cells. Am J Physiol 283:L830–L838Google Scholar
  21. 21.
    Qa’Dan M, Ramsey M, Daniel J et al (2002) Clostridium difficile toxin B activates dual caspase-dependent and caspase-independent apoptosis in intoxicated cells. Cell Microbiol 4:425–434PubMedCrossRefGoogle Scholar
  22. 22.
    Warny M, Kelly CP (1999) Monocytic cell necrosis is mediated by potassium depletion and caspase-like proteases. Am J Physiol 276:C717–C724PubMedGoogle Scholar
  23. 23.
    Solomon K, Webb J, Ali N, Robins RA, Mahida YR (2005) Monocytes are highly sensitive to clostridium difficile toxin A-induced apoptotic and nonapoptotic cell death. Infect Immun 73:1625–1634PubMedCrossRefGoogle Scholar
  24. 24.
    Boatright KM, Salvesen GS (2003) Mechanisms of caspase activation. Curr Opin Cell Biol 15:725–731PubMedCrossRefGoogle Scholar
  25. 25.
    Kim H, Kokkotou E, Na X et al (2005) Clostridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase. Gastroenterology 129:1875–1888PubMedCrossRefGoogle Scholar
  26. 26.
    Gerhard R, Burger S, Tatge H, Genth H, Just I, Hofmann F (2005) Comparison of wild type with recombinant Clostridium difficile toxin A. Microb Pathog 38:77–83PubMedCrossRefGoogle Scholar
  27. 27.
    Teichert M, Tatge H, Schoentaube J, Just I, Gerhard R (2006) Application of mutated Clostridium difficile toxin A for determination of glucosyltransferase-dependent effects. Infect Immun 74:6006–6010PubMedCrossRefGoogle Scholar
  28. 28.
    Burger S, Tatge H, Hofmann F, Just I, Gerhard R (2003) Expression of recombinant Clostridium difficile toxin A using the Bacillus megaterium system. Biochem Biophys Res Commun 307:584–588PubMedCrossRefGoogle Scholar
  29. 29.
    Genth H, Huelsenbeck J, Hartmann B, Hofmann F, Just I, Gerhard R (2006) Cellular stability of Rho-GTPases glucosylated by Clostridium difficile toxin B. FEBS Lett 580:3565–3569PubMedCrossRefGoogle Scholar
  30. 30.
    O’Connor PM, Jackman J, Bae I et al (1997) Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res 57:4285–4300PubMedGoogle Scholar
  31. 31.
    Bunz F, Hwang PM, Torrance C et al (1999) Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J Clin Invest 104:263–269PubMedCrossRefGoogle Scholar
  32. 32.
    Brenner B, Koppenhoefer U, Weinstock C, Linderkamp O, Lang F, Gulbins E (1997) Fas- or ceramide-induced apoptosis is mediated by a Rac1-regulated activation of Jun N-terminal kinase/p38 kinases and GADD153. J Biol Chem 272:22173–22181PubMedCrossRefGoogle Scholar
  33. 33.
    Esteve P, Embade N, Perona R et al (1998) Rho-regulated signals induce apoptosis in vitro and in vivo by a p53-independent, but Bcl2 dependent pathway. Oncogene 17:1855–1869PubMedCrossRefGoogle Scholar
  34. 34.
    Rattan R, Giri S, Singh AK, Singh I (2006) Rho/ROCK pathway as a target of tumor therapy. J Neurosci Res 83:243–255PubMedCrossRefGoogle Scholar
  35. 35.
    Bobak D, Moorman J, Guanzon A, Gilmer L, Hahn C (1997) Inactivation of the small GTPase Rho disrupts cellular attachment and induces adhesion-dependent and adhesion-independent apoptosis. Oncogene 15:2179–2189PubMedCrossRefGoogle Scholar
  36. 36.
    Li X, Liu L, Tupper JC et al (2002) Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells. J Biol Chem 277:15309–15316PubMedCrossRefGoogle Scholar
  37. 37.
    Ikeda H, Nagashima K, Yanase M et al (2003) Involvement of Rho/Rho kinase pathway in regulation of apoptosis in rat hepatic stellate cells. Am J Physiol 285:G880–G886Google Scholar
  38. 38.
    Lassus P, Roux P, Zugasti O, Philips A, Fort P, Hibner U (2000) Extinction of rac1 and Cdc42Hs signalling defines a novel p53-dependent apoptotic pathway. Oncogene 19:2377–2385PubMedCrossRefGoogle Scholar
  39. 39.
    Petit P, Bréard J, Montalescot V et al (2003) Lethal toxin from Clostridium sordellii induces apoptotic cell death by disruption of mitochondrial homeostasis in HL-60 cells. Cell Microbiol 2:761–771CrossRefGoogle Scholar
  40. 40.
    Linseman DA, Laessig T, Meintzer MK et al (2001) An essential role for Rac/Cdc42 GTPases in cerebellar granule neuron survival. J Biol Chem 276:39123–39131PubMedCrossRefGoogle Scholar
  41. 41.
    Hippenstiel S, Schmeck B, Seybold J, Krull M, Eichel-Streiber C, Suttorp N (2002) Reduction of tumor necrosis factor-alpha (TNF-alpha) related nuclear factor-kappaB (NF-kappaB) translocation but not inhibitor kappa-B (Ikappa-B)-degradation by Rho protein inhibition in human endothelial cells. Biochem Pharmacol 64:971–977PubMedCrossRefGoogle Scholar
  42. 42.
    Yang S, Thor AD, Edgerton S, Yang X (2006) Caspase-3 mediated feedback activation of apical caspases in doxorubicin and TNF-alpha induced apoptosis. Apoptosis 11:1987–1997PubMedCrossRefGoogle Scholar
  43. 43.
    Yin XM (2006) Bid, a BH3-only multi-functional molecule, is at the cross road of life and death. Gene 369:7–19PubMedCrossRefGoogle Scholar
  44. 44.
    Chi S, Chang S, Park D (2004) Pak regulates calpain-dependent degradation of E3b1. Biochem Biophys Res Commun 319:683–689PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Stefanie Nottrott
    • 1
  • Janett Schoentaube
    • 1
  • Harald Genth
    • 1
  • Ingo Just
    • 1
  • Ralf Gerhard
    • 1
    Email author
  1. 1.Institute of Toxicology, Hannover Medical SchoolHannoverGermany

Personalised recommendations